Strs Ohio Sangamo Therapeutics, Inc Transaction History

Strs Ohio

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 25, 2022	BUY	$3.28 - $6.21 $11,480 - $21,735	3,500 Added 6.06%	61,300 $253,000
Q3 2021 Oct 22, 2021	BUY	$9.01 - $12.01 $153,170 - $204,170	17,000 Added 41.67%	57,800 $520,000
Q2 2021 Jul 26, 2021	BUY	$10.17 - $12.64 $47,799 - $59,408	4,700 Added 13.02%	40,800 $488,000
Q1 2021 Apr 23, 2021	BUY	$10.88 - $17.05 $36,992 - $57,970	3,400 Added 10.4%	36,100 $452,000
Q4 2020 Jan 25, 2021	BUY	$9.23 - $18.18 $301,821 - $594,486	32,700 New	32,700 $510,000
Q4 2018 Jan 23, 2019	SELL	$9.51 - $16.6 $223,485 - $390,100	-23,500 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$13.05 - $19.05 $169,650 - $247,650	-13,000 Reduced 35.62%	23,500 $398,000
Q2 2018 Aug 06, 2018	BUY	$13.9 - $19.8 $45,870 - $65,340	3,300 Added 9.94%	36,500 $518,000
Q1 2018 Apr 20, 2018	BUY	$16.7 - $26.35 $51,770 - $81,685	3,100 Added 10.3%	33,200 $630,000
Q3 2017 Oct 23, 2017	BUY	$8.4 - $15.0 $252,840 - $451,500	30,100	30,100 $451,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $136M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.